252 related articles for article (PubMed ID: 33019620)
1. The Toxin-Antitoxin Systems of the Opportunistic Pathogen
Klimkaitė L; Armalytė J; Skerniškytė J; Sužiedėlienė E
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019620
[No Abstract] [Full Text] [Related]
2. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
3. Review on
Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia drug resistance.
Sanchez MB; Hernandez A; Martinez JL
Future Microbiol; 2009 Aug; 4(6):655-60. PubMed ID: 19659422
[TBL] [Abstract][Full Text] [Related]
5. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.
Brooke JS
Clin Microbiol Rev; 2012 Jan; 25(1):2-41. PubMed ID: 22232370
[TBL] [Abstract][Full Text] [Related]
6. Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus.
Chanyi RM; Koval SF; Brooke JS
Environ Microbiol Rep; 2016 Jun; 8(3):343-51. PubMed ID: 26929093
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing.
Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF
J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
9. The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction.
Alcaraz E; García C; Friedman L; de Rossi BP
FEMS Microbiol Lett; 2019 Mar; 366(6):. PubMed ID: 31044250
[TBL] [Abstract][Full Text] [Related]
10. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
11.
Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
[No Abstract] [Full Text] [Related]
12. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
Sannathimmappa MB; Nambiar V; Aravindakshan R; Al-Kasaby NM
Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e66-e71. PubMed ID: 33777425
[TBL] [Abstract][Full Text] [Related]
13. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia.
Gröschel MI; Meehan CJ; Barilar I; Diricks M; Gonzaga A; Steglich M; Conchillo-Solé O; Scherer IC; Mamat U; Luz CF; De Bruyne K; Utpatel C; Yero D; Gibert I; Daura X; Kampmeier S; Rahman NA; Kresken M; van der Werf TS; Alio I; Streit WR; Zhou K; Schwartz T; Rossen JWA; Farhat MR; Schaible UE; Nübel U; Rupp J; Steinmann J; Niemann S; Kohl TA
Nat Commun; 2020 Apr; 11(1):2044. PubMed ID: 32341346
[TBL] [Abstract][Full Text] [Related]
14. Comparative Genomics of Environmental and Clinical Stenotrophomonas maltophilia Strains with Different Antibiotic Resistance Profiles.
Youenou B; Favre-Bonté S; Bodilis J; Brothier E; Dubost A; Muller D; Nazaret S
Genome Biol Evol; 2015 Aug; 7(9):2484-505. PubMed ID: 26276674
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and Transcriptomic Analyses of Seven Clinical Stenotrophomonas maltophilia Isolates Identify a Small Set of Shared and Commonly Regulated Genes Involved in the Biofilm Lifestyle.
Alio I; Gudzuhn M; Pérez García P; Danso D; Schoelmerich MC; Mamat U; Schaible UE; Steinmann J; Yero D; Gibert I; Kohl TA; Niemann S; Gröschel MI; Haerdter J; Hackl T; Vollstedt C; Bömeke M; Egelkamp R; Daniel R; Poehlein A; Streit WR
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 33097507
[No Abstract] [Full Text] [Related]
16. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
Abbott IJ; Slavin MA; Turnidge JD; Thursky KA; Worth LJ
Expert Rev Anti Infect Ther; 2011 Apr; 9(4):471-88. PubMed ID: 21504403
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain.
Lira F; Hernández A; Belda E; Sánchez MB; Moya A; Silva FJ; Martínez JL
J Bacteriol; 2012 Jul; 194(13):3563-4. PubMed ID: 22689246
[TBL] [Abstract][Full Text] [Related]
18. Advances in the Microbiology of Stenotrophomonas maltophilia.
Brooke JS
Clin Microbiol Rev; 2021 Jun; 34(3):e0003019. PubMed ID: 34043457
[TBL] [Abstract][Full Text] [Related]
19. Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.
Nas MY; Gabell J; Cianciotto NP
mBio; 2021 Jun; 12(3):e0150221. PubMed ID: 34182776
[TBL] [Abstract][Full Text] [Related]
20. The opportunistic pathogen Stenotrophomonas maltophilia utilizes a type IV secretion system for interbacterial killing.
Bayer-Santos E; Cenens W; Matsuyama BY; Oka GU; Di Sessa G; Mininel IDV; Alves TL; Farah CS
PLoS Pathog; 2019 Sep; 15(9):e1007651. PubMed ID: 31513674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
